Literature DB >> 21388446

Liraglutide therapy in Prader-Willi syndrome.

K Cyganek, T Koblik, E Kozek, M Wojcik, J Starzyk, M T Malecki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21388446     DOI： 10.1111/j.1464-5491.2011.03280.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  6 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

3.  Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.

Authors:  P Salehi; I Hsu; C G Azen; S D Mittelman; M E Geffner; D Jeandron
Journal:  Pediatr Obes       Date:  2016-04-13       Impact factor: 4.000

Review 4.  Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome.

Authors:  Jennifer L Miller; Theresa V Strong; Janalee Heinemann
Journal:  Diseases       Date:  2015-06-03

5.  Intensive management of obesity in people with Prader-Willi syndrome.

Authors:  Brendan J Nolan; Joseph Proietto; Priya Sumithran
Journal:  Endocrine       Date:  2022-05-07       Impact factor: 3.925

6.  Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity.

Authors:  Marina Caputo; Tommaso Daffara; Simonetta Bellone; Valentina Mancioppi; Paolo Marzullo; Gianluca Aimaretti; Flavia Prodam
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-22       Impact factor: 5.555
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.